Clozapine replacement by quetiapine for dopamimetic psychosis in Parkinson's disease

被引：0
|
作者：
Fernandez, H
Friedman, JH
Lannon, MC
机构：
来源：
ANNALS OF NEUROLOGY | 1999年 / 46卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：491 / 491
页数：1
相关论文
共 50 条
  • [1] Clozapine serum concentrations in dopamimetic psychosis in Parkinson's disease and related disorders
    Lutz, Ulrich C.
    Sirfy, Ahmad
    Wiatr, Gerlinde
    Altpass, Danuta
    Farger, Gisbert
    Gasser, Thomas
    Karle, Kathrin N.
    Batra, Anil
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (12) : 1471 - 1476
  • [2] Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
    Fernandez, HH
    Lannon, MC
    Friedman, JH
    Abbott, BP
    MOVEMENT DISORDERS, 2000, 15 (03) : 579 - 581
  • [3] Clozapine serum concentrations in dopamimetic psychosis in Parkinson’s disease and related disorders
    Ulrich C. Lutz
    Ahmad Sirfy
    Gerlinde Wiatr
    Danuta Altpaß
    Gisbert Farger
    Thomas Gasser
    Kathrin N. Karle
    Anil Batra
    European Journal of Clinical Pharmacology, 2014, 70 : 1471 - 1476
  • [4] Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease
    Dewey, RB
    O'Suilleabhain, PE
    NEUROLOGY, 2000, 55 (11) : 1753 - 1754
  • [5] Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease
    Brandstädter, D
    Oertel, WH
    NEUROLOGY, 2002, 58 (01) : 160 - 161
  • [6] Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease - Reply
    Dewey, RB
    O'Suilleabhain, PE
    NEUROLOGY, 2002, 58 (01) : 161 - 161
  • [7] Rater-blinded, prospective comparison: Quetiapine versus clozapine for Parkinson's disease psychosis
    Merims, Doron
    Balas, Meirav
    Peretz, Chava
    Shabtai, Herzel
    Giladi, Nir
    CLINICAL NEUROPHARMACOLOGY, 2006, 29 (06) : 331 - 337
  • [8] Quetiapine, Clozapine, and Pimavanserin Treatment Response in Monogenic Parkinson's Disease Psychosis: A Systematic Review
    Colijn, Mark Ainsley
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2025, 37 (01) : 6 - 13
  • [9] THE COST-EFFECTIVENESS OF CLOZAPINE VS. QUETIAPINE IN THE TREATMENT OF PARKINSON'S DISEASE PSYCHOSIS
    Chekani, F.
    Sansgiry, S. S.
    VALUE IN HEALTH, 2017, 20 (05) : A193 - A193
  • [10] Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios
    Hubbard, David
    Hacksell, Uli
    McFarland, Krista
    BEHAVIOURAL PHARMACOLOGY, 2013, 24 (07): : 628 - 632
12345